Compositions and methods for the diagnosis prevention and treatment of tumor progression

Patent Citations (19)

Non-Patent Literature (42)

• Duncan et al. “Fomy030 expression in melanocytic proliferations” Melanoma Res. 7(1):S7, 1997.Applicant
• Fidler, I.J., 1973, “Selection of Successive Tumor Lines for Metastasis,” Nature New Biol. 242:148-149.Applicant
• Fodde, R., et al., 1994, “A targeted chain-termination mutation in the mouse Apc gene results in multiple intestinal tumors,” Proc. Natl. Acad. Sci. USA 91:8969-8973.Applicant
• Folkman, J. and Klagsburn, M., 1987, “Angiogenic Factors,” Science 235:442.Applicant
• Hiller et al., “AC No. N42635. Homosapiens cDNA clone 270851” EMBL Sequence Database, Heidelberg, Germany, Jan. 28, 1996.Applicant
• Hiller et al., “AC No. N42983. Homosapiens cDNA clone 270601” EMBL Sequence Database, Heidelberg, Germany, Jan. 28, 1996.Applicant
• Hodgkinson, C.A., et al., 1993, “Mutations at the Mouse Microphthalmia Locus Are Associated with Defects in a Gene Encoding a Novel Basic-Helix-Loop-Helix-Zipper Protein,” Cell 74:395-404.Applicant
• Karmali, R.A., et al., 1993, “Prostaglandins in beast cancer: Relationship to disease stage and hormone status,” Br. J. Cancer 48:689-696.Applicant
• Karmali, R.A., et al., 1987, “The Effects of Dietary ω-3 Fatty Acids on the DU-145 Transplantable Human Prostatic Tumor,” Anticancer Res. 7:1173-1180.Applicant
• Kozlowski, J.M., et al., 1984, “Metastatic Behavior of Human Tumor Cell Lines Grown in the Nude Mouse,” Cancer Research 44:3522-3529.Applicant
• Leder, A., et al., 1986, “Consequences of widespread deregulation of the C-MYC gene in transgenic mice: multiple neoplasms and normal development,” Cell 45:485-495.Applicant
• Leone, A., et al., 1991, “Reduced Tumor Incidence, Metastatic Potential, and Cytokine Responsiveness of nm23-Transfected Melanoma Cells,” 65:25-35.Applicant
• Liotta, L.A., et al., 1991, “Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation,” Cell 64:327.Applicant
• Mintz, B., and Silvers, W.K., 1993, “Transgenic mouse model of malignant skin melanoma,” Proc. Natl. Acad. Sci. USA 90:8817-8821.Applicant
• Morikawa K., et al., 1988, “In Vivo Selection of Highly Metastatic Cells from Surgical Specimens of Different Primary Human Colon Carcinomas Implanted into Nude Mice,” Cancer Research 48:1943-1948.Applicant
• Qian, F., et al., 1994, “Expression of the Integrin α4β1 on Melanoma Cells Can Inhibit the Invasive Stage of Metastasis Formation,” Cell 77:335-347.Applicant
• Rose, D.P., et al., 1993, “Effects of Dietary Omega-3 Fatty Acids on Human Breast Cancer Growth and Metastases in Nude Mice,” J. Natl. Cancer Inst. 851743-1747.Applicant
• Schrier, P.I., et al., 1983, Expression of Class 1 major histocompatibility antigens switched off by highly oncogenic adenovirus 12 in transformed rat cells, Nature 305:771.Applicant
• Steeg, P.S., et al., 1988, “Evidence for a Novel Gene Associated With Low Tumor Metastatic Potential,” J. Natl. Cancer Inst. 80:200-204.Applicant
• Tanaka et al., “Construction of a Human Cytochrome c Gene and Its Functional Expression in Saccharomyces cerevisiae”, J. Biochem., 103:954-961 (1988).Applicant
• Van der Bruggen, P., et al., 1991, “A Gene Encoding an Antigen Recognized by Cytolytic T Lymphocytes on a Human Melanoma,” Science 254:1643-1667.Applicant
• Vogelstein, B., and Kinzler, K.W., 1993, “The Multistep Nature of Cancer,” Trends Genet. 9:138-141.Applicant
• Watts C.K., et al., 1994, “Antiestrogen regulation of cell cycle progression and cyclin D1 gene expression in MCF-7 human breast cancer cells,” Breast Cancer Res. Treat. 31:95-105.Applicant
• Wilson et al., “2.2 Mb of contiguous nucleotide sequence from chromosome III of C. elegans”, Nature, 368:32-38 (1994).Applicant
• Zou, Z., et al., 1994, “Maspin, A Serpin with Tumor-Suppressing Activity in Human Mammary Epithelial Cells,” Science 263:526-529.Applicant
• Masson et al., “Pharmacokinetic optimisation of cancer chemotherapy. Effect on outcomes”, Clinical Pharmacokinetics, vol. 32 (4), pp. 324-343, Apr. 1997.Applicant
• Barton et al., “Protein Sequence Alignment and Database Scanning In Protein Structure Prediction” IRL Press at Oxford University, pp. 31-63, 1996.Applicant
• Boeringer Mannheim Biochemicals, 1991 Catalog.Applicant
• Bowie et al., “Deciphering the Message in Protein Sequences; Tolerance to Amino Acid Substitutions” Science 247:1306, 1990.Applicant
• Burgess et al., “Possible Dissociation of the Heparin-binding and Mitogenic Acitivities . . . ” J. Cell. Biol. 111:2129, 1990.Applicant
• George et al., Current Methods in Sequence Comparison and Analysis In Macromolecular Sequencing and Synthesis, Selected Methods and Applications, pp. 127-149, 1988.Applicant
• Fradet et al., “Cell Surface of Human Bladder Cancer Defined by Mouse Monoclonal Antibodies” Proc. Nat'l. Acad. Sci. USA 81:224, 1984.Applicant
• Harris et al., “Seminal Vesicle Secretion IV Gene; Allelic Difference Due to a Series of . . . ” Proc. Nat'l. Acad. Sci. USA 80:6460, 1983.Applicant
• Hillier et al., Accession No. N24756, Dec. 28, 1995.Applicant
• Kahana et al., “Nucleotide Sequence of Murine Ornithine Decarboxylase mRNA” Proc. Nat'l. Acad. Sci. USA 82:1673, 1985.Applicant
• Lazar et al. “Transforming Growth Factor alpha: Mutation of Aspartic Acid 47 and Leucine . . . ” Mol. Cell. Biol. 8:1247, 1988.Applicant
• Lewis et al., “The Sequence of the Kluyveromyces Lactis BiP Gene” Nucl. Acids. Res. 18:6438, 1990.Applicant
• Rieger et al., “Glossary of Genetics and Cytogenetics, Classical and Molecular” Springe-Vertag, Berlin, 4th Edition, 1976.Applicant
• Schwartz et al., “A Superactive Insulin: [B10-Aspartic Acid] Insulin(Human)” Proc. Nat'l. Acad. Sci. USA 84:6408, 1987.Applicant
• Strategene Catalog, p. 39, 1988.Applicant
• Wang et al., “Identification and Molecular Cloning of Tactile” J. of Immun. 148(8):2600-2608, 1992.Applicant
• Zubay, G., Biochemistry, p. 912, Addison Esley Publishing Co., Reading, MA, 1984.Applicant